Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®
Public ClinicalTrials.gov record NCT01591902. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Randomized, Placebo-controlled, Double-blind Clinical Trial to Evaluate Whether EGRIFTA® (Tesamorelin for Injection), 2 mg Once Daily SC, Increases the Risk of Development or Progression of Diabetic Retinopathy When Administered to HIV-infected Subjects With Abdominal Lipohypertrophy and Concomitant Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To show the non-inferiority of EGRIFTA® vs. placebo in the development or progression of Diabetic Retinopathy in HIV-infected subjects with concomitant abdominal lipohypertrophy and Type 2 diabetes mellitus (T2DM).
Study identification
- NCT ID
- NCT01591902
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 129 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2012 (Actual)
- Primary completion
- May 2018 (Actual)
- Completion
- Aug 2018 (Actual)
- Last update posted
- Sep 11, 2018
2012 – 2018
United States locations
- U.S. sites
- 24
- U.S. states
- 11
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southwest Center for HIV/AIDS | Phoenix | Arizona | 85004 | — |
| Spectrum Medical Group | Phoenix | Arizona | 85012 | — |
| 5P21 Rand Schrader Clinic | Los Angeles | California | 90033 | — |
| University of California CARE Clinic, Los Angeles | Los Angeles | California | 90035 | — |
| Palmtree Clinical Research, Inc. | Palm Springs | California | 92262 | — |
| UCSD Antiviral Research Center | San Diego | California | 92103 | — |
| VAMC, Infectious Disease Section 111W | San Francisco | California | 94121 | — |
| Capital Medical Associates, PC | Washington D.C. | District of Columbia | 20036 | — |
| Gary J. Richmond, M.D., PA | Fort Lauderdale | Florida | 33316 | — |
| Orange County Health Department | Orlando | Florida | 32809 | — |
| Triple O Research Institute | West Palm Beach | Florida | 33401 | — |
| Rowan Tree Medical , P.A. | Wilton Manors | Florida | 33305 | — |
| Be Well Medical Center, P.C. | Berkley | Michigan | 48072-3436 | — |
| Southampton Clinical Research, Inc d.b.a. Central West Clinical Research | St Louis | Missouri | 63108 | — |
| Southampton Healthcare, Inc. | St Louis | Missouri | 63139 | — |
| South Jersey Infectious Disease | Somers Point | New Jersey | 08244 | — |
| Harold Hamm Diabetes Center at the University of Oklahoma | Oklahoma City | Oklahoma | 73104 | — |
| Fanno Creek Clinic, LLC | Portland | Oregon | 97219 | — |
| Central Texas Clinical Research | Austin | Texas | 78705 | — |
| St. Hope Foundation, Inc. | Bellaire | Texas | 77401 | — |
| Dallas VA Medical Center | Dallas | Texas | 75216 | — |
| UT Southwestern Medical Center, Atten: HIV Research Unit | Dallas | Texas | 75235 | — |
| Research Access Network | Houston | Texas | 77098 | — |
| Virginia Mason Medical Center | Seattle | Washington | 98112 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01591902, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 11, 2018 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01591902 live on ClinicalTrials.gov.